MiRus Launches STAR Trial for Innovative Siegel™ Aortic Valve Treatment MiRus has begun patient enrollment for the STAR Trial, focusing on the Siegel™ aortic transcatheter heart valve, aiming to enhance treatment options for aortic stenosis.

MiRus Launches STAR Trial for Innovative Siegel™ Aortic Valve Treatment #United_States #Atlanta #MiRus #Siegel #Aortic_Valve

Transcatheter Aortic Valve Replacement in Patients ≥80 and &lt;80 Years of Age with Aortic Valve Stenosis at Moderate Surgical Risk: Findings from an Observational Study in the Vietnamese Population <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d5148682e247"> <b>Objectives:</b> The increasing number of elderly patients with severe a...

Transcatheter #Aortic_Valve Replacement in Patients ≥80 and <80 Years of Age with Aortic Valve Stenosis at Moderate Surgical Risk. Click the link below to read this #open_access article #cardiology #CardioSky #MedSky www.scienceopen.com/hosted-docum...

Transcatheter Aortic Valve Replacement in Patients ≥80 and &lt;80 Years of Age with Aortic Valve Stenosis at Moderate Surgical Risk: Findings from an Observational Study in the Vietnamese Population <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d5148682e247"> <b>Objectives:</b> The increasing number of elderly patients with severe a...

Transcatheter #Aortic_Valve Replacement in Patients ≥80 and <80 Years of Age with Aortic Valve Stenosis at Moderate Surgical Risk. Click the link below to read this #open_access article #cardiology #CardioSky #MedSky www.scienceopen.com/hosted-docum...